Bobulsky Susan insider trades
Bobulsky Susan has filed 14 Form 4s with the SEC that we hold, all for Adaptive Biotechnologies Corp (ADPT), as Chief Commercial Officer, MRD. Across all of them we count 0 purchases worth $0 and 13 sales worth $1.6M reported on Form 4. In the last 12 months: 0 purchases ($0) and 10 sales ($1.4M). The largest single trade was a sale of 41,338 shares of Adaptive Biotechnologies Corp worth $544.4K, dated 2026-03-11. Of 2 sales filed since we began reading the 10b5-1 checkbox, 2 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2024-03-06 and the latest 2026-10-08.
Adaptive Biotechnologies Corp (ADPT)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-03-05 | S, sale reported on Form 4 | 6,975 | $24.0K | 2024-03-06 |
| 2024-03-05 | S, sale reported on Form 4 | 6,016 | $20.6K | 2024-03-06 |
| 2025-03-05 | S, sale reported on Form 4 | 26,023 | $181.6K | 2025-03-06 |
| 2026-03-11 | S, sale reported on Form 4 | 41,338 | $544.4K | 2026-03-13 |
| 2026-06-04 | S, sale reported on Form 4 | 11,000 | $198.0K | 2026-06-08 |
| 2026-06-11 | S, sale reported on Form 4 | 5,000 | $95.0K | 2026-06-15 |
| 2026-06-25 | S, sale reported on Form 4 | 5,000 | $102.5K | 2026-06-29 |
| 2026-07-01 | S, sale reported on Form 4 | 487 | $10.7K | 2026-07-06 |
| 2026-07-16 | S, sale reported on Form 4 | 5,000 | $115.0K | 2026-07-20 |
| 2026-07-30 | S, sale reported on Form 4 | 1,299 | $31.2K | 2026-08-03 |
| 2026-08-10 | S, sale reported on Form 4 | 3,000 | $75.0K | 2026-08-12 |
| 2026-09-15 | S, sale reported on Form 4 | 1,195 | $32.3K | 2026-09-17 |
| 2026-10-06 | S, sale reported on Form 4 | 6,444 | $193.3K | 2026-10-08 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1820885) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms